Tyml K, Yu J, McCormack D G
A. C. Burton Vascular Biology Laboratory, Victoria Hospital Research Institute, University of Western Ontario, London, Ontario, Canada N6A 5C1.
J Appl Physiol (1985). 1998 Mar;84(3):837-44. doi: 10.1152/jappl.1998.84.3.837.
Although sepsis is known to affect vascular function, little is known about changes at the capillary level. We hypothesized that sepsis attenuates the "upstream" arteriolar response to vasoactive agents applied locally to capillaries. Sepsis in rats was induced by cecal ligation and perforation. After 24 h, extensor digitorum longus muscle was prepared for intravital microscopy. Phenylephrine (PE, 10 mM) and acetylcholine (ACh, 10 mM) were applied iontophoretically on terminal arterioles and on their downstream daughter capillaries (300 micron from arteriole). There was no significant difference between control and septic rats in baseline arteriolar diameters [8.0 +/- 0.6 vs. 9.8 +/- 0.8 (SE) micron- or baseline red blood cell velocity (VRBC) in perfused daughter capillaries (255 +/- 10 vs. 264 +/- 13 micron/s). Application of PE onto arterioles resulted in comparable constrictions (i.e., -22% diameter change) and VRBC reductions (-100%) in control and septic rats. In contrast, arteriolar diameter and VRBC increases after application of ACh were attenuated in sepsis (diameter: from 41 to 14%; VRBC: from 67 to 24%). Application of PE onto the capillary reduced VRBC to the same level (-100%) in both groups, whereas application of ACh increased VRBC less in septic than in control rats (20 vs. 73%). On the basis of arteriolar-capillary pair stimulations, sepsis affected VRBC responses to ACh more in the capillary than in the arteriole. When the adenosine analog 5'-N-ethylcarboxamidoadenosine (0.1 mM) was used instead of ACh, similar effects of sepsis were seen. To test for a possible involvement of inducible NO synthase (iNOS) in sepsis-induced attenuated ACh responses, arterioles and capillaries in septic animals were locally pretreated with the iNOS blocker aminoguanidine (10 mM). In both microvessels, aminoguanidine restored the ACh response to the control level. We conclude that impaired capillary VRBC and arteriolar diameter responses to vasodilators applied to capillaries in septic rat skeletal muscle were due to dysfunction at arteriolar and capillary levels. The study underscores the significant role iNOS/NO may play in sepsis-induced alteration of vascular reactivity in vivo.
尽管已知脓毒症会影响血管功能,但对于毛细血管水平的变化却知之甚少。我们推测脓毒症会减弱局部应用于毛细血管的血管活性药物所引发的“上游”小动脉反应。通过盲肠结扎和穿孔诱导大鼠发生脓毒症。24小时后,制备趾长伸肌用于活体显微镜检查。将去氧肾上腺素(PE,10 mM)和乙酰胆碱(ACh,10 mM)通过离子电渗法应用于终末小动脉及其下游的子毛细血管(距小动脉300微米处)。对照组和脓毒症大鼠在基础小动脉直径[8.0±0.6 vs. 9.8±0.8(SE)微米]或灌注子毛细血管中的基础红细胞速度(VRBC)[255±10 vs. 264±13微米/秒]方面无显著差异。在对照组和脓毒症大鼠中,将PE应用于小动脉会导致类似程度的收缩(即直径变化-22%)和VRBC降低(-100%)。相比之下,脓毒症时应用ACh后小动脉直径和VRBC的增加减弱(直径:从41%降至14%;VRBC:从67%降至24%)。在两组中,将PE应用于毛细血管均使VRBC降至相同水平(-100%),而应用ACh时,脓毒症大鼠中VRBC的增加幅度小于对照组大鼠(20%对73%)。基于小动脉-毛细血管对的刺激,脓毒症对VRBC对ACh反应的影响在毛细血管中比在小动脉中更明显。当使用腺苷类似物5'-N-乙基羧酰胺腺苷(0.1 mM)代替ACh时,观察到脓毒症有类似的作用。为了测试诱导型一氧化氮合酶(iNOS)是否可能参与脓毒症诱导的ACh反应减弱,对脓毒症动物的小动脉和毛细血管进行局部预处理,使用iNOS阻滞剂氨基胍(10 mM)。在两种微血管中,氨基胍将ACh反应恢复到对照水平。我们得出结论,脓毒症大鼠骨骼肌中毛细血管VRBC和小动脉直径对应用于毛细血管的血管舒张剂的反应受损是由于小动脉和毛细血管水平的功能障碍所致。该研究强调了iNOS/NO在脓毒症诱导的体内血管反应性改变中可能发挥的重要作用。